AI tool detects hard-to-identify heart dysfunction from standard ECGs
Wake Forest University School of Medicine researchers show AI analysis of ECG data could make screening for heart dysfunction more accessible
Publisher: Newswise
Premature Blood Stem Cell Aging in Sickle Cell Disease May Be Reversible
Scientists at St. Jude Children’s Research Hospital found that prematurely old blood stem cells from sickle cell disease may be treatable with anti-aging drugs, and highlight a needed improvement to gene therapies.
Routine Heart Test Can Track How Kids Grow and Mature, New Study Finds
A new study from Wake Forest University School of Medicine suggests a routine heart test – an electrocardiogram (ECG) – may offer researchers a new way to measure biological development in children and adolescents.
CHLA Joins Trial of Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia
The landmark national study aims to better guide early respiratory care for babies with CDH.
Study Reveals Critical Impact of Universal cCMV Screening on Early Detection of Hearing Loss in Newborns
Eight-year Memphis study shows one-third of hearing loss cases develop after birth, reinforcing need for universal screening as Academy advances federal and state legislation
Approach to Combat Antibiotic Resistance Turns Bacterium’s Genes Against It
Scientists at St. Jude Children’s Research Hospital have found a way to use a bacterium’s own drug resistance mechanisms against itself, presenting a potentially safer and more effective way to treat certain antibiotic-resistant infections.
Ochsner Novant Health 65 Plus – Bellview welcomes Brandon M. McElroy, MD
Ochsner Novant Health 65 Plus – Bellview welcomes Brandon M. McElroy, MD, a board-certified internal medicine physician.
‘Molecular Glue’ Harnesses the Power of the Immune System to Treat Neuroblastoma
Published today in Nature Communications, a collaborative effort led by corresponding author Jun Yang, MD, PhD, St. Jude Department of Surgery, uncovered hidden layers of neuroblastoma plasticity, and investigated the ability of the drug indisulam combined with immunotherapy to bypass it.